Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning.

[1]  L. V. D. Berg.  The Musculoskeletal System in Pompe Disease: Pathology, consequences and treatment options , 2014 .

[2]  B. Schoser,et al.  Pain in adult patients with Pompe disease: a cross-sectional survey. , 2013, Molecular genetics and metabolism.

[3]  S. Peltz,et al.  THE 6-MINUTE WALK TEST AND OTHER ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: LONGITUDINAL NATURAL HISTORY OBSERVATIONS OVER 48 WEEKS FROM A MULTICENTER STUDY , 2013, Muscle & nerve.

[4]  W. Hop,et al.  Enzyme replacement therapy and fatigue in adults with Pompe disease , 2013, BMC Musculoskeletal Disorders.

[5]  R. D'Agostino,et al.  Impact of enzyme replacement therapy on survival in adults with Pompe disease , 2013, BMC Musculoskeletal Disorders.

[6]  J. Vries,et al.  Exercise Capacity, Muscle Strength, and Fatigue in Sarcoidosis: A Follow-Up Study , 2013, Lung.

[7]  R. Motl,et al.  Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls , 2013, Disability and rehabilitation.

[8]  P. Doorn,et al.  The Rasch-built Pompe-specific Activity (R-PAct) scale , 2013, Neuromuscular Disorders.

[9]  W. Hop,et al.  Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study , 2012, Orphanet Journal of Rare Diseases.

[10]  I. Fatouros,et al.  Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. , 2011, Molecular genetics and metabolism.

[11]  Nick Ball,et al.  Influence of dynamic versus static core exercises on performance in field based fitness tests. , 2010, Journal of bodywork and movement therapies.

[12]  A. Pestronk,et al.  A randomized study of alglucosidase alfa in late-onset Pompe's disease. , 2010, The New England journal of medicine.

[13]  A. Reuser,et al.  Pompe's disease , 2008, The Lancet.

[14]  C. Winstein,et al.  Effects of Task-Specific Locomotor and Strength Training in Adults Who Were Ambulatory After Stroke: Results of the STEPS Randomized Clinical Trial , 2007, Physical Therapy.

[15]  D. Rafferty,et al.  Specificity of recumbent cycling as a training modality for the functional movements; sit-to-stand and step-up. , 2007, Clinical biomechanics.

[16]  B. Schlotter-Weigel,et al.  Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients , 2007, Neuromuscular Disorders.

[17]  A. Janssens,et al.  Fatigue: an important feature of late-onset Pompe disease , 2007, Journal of Neurology.

[18]  J. Galanko,et al.  Modification of the natural history of adult‐onset acid maltase deficiency by nutrition and exercise therapy , 2007, Muscle & nerve.

[19]  Stewart G Trost,et al.  Conducting accelerometer-based activity assessments in field-based research. , 2005, Medicine and science in sports and exercise.

[20]  W. Hop,et al.  Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. , 2005, Brain : a journal of neurology.

[21]  John E. Ware,et al.  SF-36 Health Survey Update , 2000, Spine.

[22]  P. Schmitz,et al.  Fatigue in immune-mediated polyneuropathies , 1999, Neurology.

[23]  N. Aaronson,et al.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. , 1998, Journal of clinical epidemiology.

[24]  L. Makrides,et al.  Normal standards for an incremental progressive cycle ergometer test. , 1985, The American review of respiratory disease.

[25]  F. Glocker,et al.  Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial , 2009, Journal of Neurology.

[26]  Koen A.P.M. Lemmink,et al.  This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. The Importance of Sensory-Motor Control in Providing Core Stability Implications for Measurement and Training , 2008 .

[27]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[28]  J. Melvin.  Pompe's disease. , 2000, Archives of neurology.

[29]  P. Schmitz,et al.  Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. , 1999, Neurology.

[30]  B. Leutholtz,et al.  The effects of exercise on a patient with severe acid maltase deficiency , 1996 .

[31]  Cellular and Molecular Life Sciences REVIEW Fatigue in neuromuscular disorders: focus on Guillain–Barré , 2022 .

[32]  H. Duivenvoorden,et al.  Communicated by: Olaf Bodamer , 2022 .